Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Parkinson's Disease is Scopus-indexed (Q2, CiteScore 4.7), WoS SCIE, DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 2042-0080Verify ISSN ↗2090-8083Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Psychiatry and Mental Health | 199 / 580 | 65th | Q2 |
| Neurology (clinical) | 146 / 403 | 63rd | Q2 |
| Neuroscience (miscellaneous) | 30 / 74 | 60th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present (also 2008), best quartile Q2, CiteScore 4.7.
Parkinson's Disease is Q2 in Psychiatry and Mental Health (rank 199 of 580), Q2 in Neurology (clinical) (rank 146 of 403) and Q2 in Neuroscience (miscellaneous) (rank 30 of 74), by CiteScore 2025.
Parkinson's Disease is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.7, which places it in quartile Q2 at the 65th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.722, quartile Q2, with an H-index of 67.
The publisher lists an article processing charge of about US$2,160 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Parkinson's Disease is published by John Wiley and Sons Ltd. Its print ISSN is 2042-0080 and its online ISSN is 2090-8083.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Parkinson's Disease has an h-index of 74 and a 2-year mean of 1.83 citations per paper (OpenAlex). Its Scopus CiteScore is 4.7, quartile Q2. On 2-year citations it ranks #232 of 570 Scopus journals in Psychiatry and Mental Health.
Parkinson's Disease published 32 papers in 2025; its busiest recent year was 2020 with 75. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2023–2026), authors are most often from China (16.8%), United Kingdom (11.9%) and United States (10.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.